Singapore markets closed
Straits Times Index
3,209.18 +29.60 (+0.93%) S&P 500
4,039.08 +60.35 (+1.52%) Dow
32,582.32 +462.04 (+1.44%) Nasdaq
11,634.37 +199.63 (+1.75%) BTC-USD
29,195.51 -564.09 (-1.90%) CMC Crypto 200
639.25 -21.90 (-3.31%)
Moderna, Inc. (MRNA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:44AM EDT. Market open.
| Previous close | 130.85 |
| Open | 130.85 |
| Bid | 131.34 x 1200 |
| Ask | 131.27 x 1000 |
| Day's range | 126.53 - 132.32 |
| 52-week range | 119.01 - 497.49 |
| Volume | |
| Avg. volume | 6,887,137 |
| Market cap | 52.234B |
| Beta (5Y monthly) | 1.70 |
| PE ratio (TTM) | 3.86 |
| EPS (TTM) | 34.02 |
| Earnings date | 03 Aug 2022 - 08 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 220.00 |
- Motley Fool
Better Buy Ahead of FDA Meetings: Moderna vs. Novavax
Moderna (NASDAQ: MRNA) and Novavax (NASDAQ: NVAX) both delivered major returns for investors in the early days of the coronavirus vaccine race. Moderna's vaccine entered the market in December of 2020. Novavax's vaccine began winning authorizations a year later -- but isn't yet approved in the United States.
- Motley Fool
4 Nasdaq 100 Stocks Billionaires Piled Into During the First Quarter
Successful money managers used the Nasdaq bear market as a catalyst to buy into these high-growth stocks.
- Zacks
AstraZeneca (AZN) Gets EU Nod for COVID-19 Booster Shot
AstraZeneca's (AZN) third/booster dose of its COVID-19 vaccine gets authorized in Europe for use in adults, both for homologous and heterologous use.
© 2022 Yahoo. All rights reserved.
